Cargando…

The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma

To explore the prognostic values of baseline 2‐deoxy‐2‐[(18)F] fluoro‐D‐glucose (FDG) positron emission tomography/computed tomography (PET/CT) dissemination parameter in angioimmunoblastic T‐cell lymphoma (AITL) and its added values to total metabolic tumour volume (TMTV). Eighty‐one AITL patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Huanyu, Tang, Bo, Li, Tiannv, Li, Jianyong, Tang, Lijun, Ding, Chongyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928789/
https://www.ncbi.nlm.nih.gov/pubmed/36819177
http://dx.doi.org/10.1002/jha2.610
_version_ 1784888716610764800
author Gong, Huanyu
Tang, Bo
Li, Tiannv
Li, Jianyong
Tang, Lijun
Ding, Chongyang
author_facet Gong, Huanyu
Tang, Bo
Li, Tiannv
Li, Jianyong
Tang, Lijun
Ding, Chongyang
author_sort Gong, Huanyu
collection PubMed
description To explore the prognostic values of baseline 2‐deoxy‐2‐[(18)F] fluoro‐D‐glucose (FDG) positron emission tomography/computed tomography (PET/CT) dissemination parameter in angioimmunoblastic T‐cell lymphoma (AITL) and its added values to total metabolic tumour volume (TMTV). Eighty‐one AITL patients with at least two FDG‐avid lesions in baseline PET/CT were retrospectively included. PET parameters including TMTV and the distance between the two lesions that are the furthest apart (Dmax) were obtained. Univariate Cox analysis showed that both Dmax and TMTV were risk factors for progression‐free survival (PFS) and overall survival (OS). Multivariate Cox analysis models of different combinations showed that high Dmax (> 65.7 cm) could independently predict both PFS and OS, while high TMTV (>456.6 cm(3)) was only significant for OS. A concise PET model based on TMTV and Dmax can effectively risk‐stratify patients. PFS and OS rates were significantly lower in patients with high Dmax and high TMTV than in patients with low Dmax and low TMTV (3‐year PFS rate: 15.0% vs. 48.7%, p = 0.001; 3‐year OS rate: 27.6% vs. 79.0%, p < 0.001). Dmax can directly reflect the disease dissemination characteristic and has a significant prognostic value for FDG‐avid AITL patients. It has the potential to be introduced into new risk stratification models for tailored treatment.
format Online
Article
Text
id pubmed-9928789
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99287892023-02-16 The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma Gong, Huanyu Tang, Bo Li, Tiannv Li, Jianyong Tang, Lijun Ding, Chongyang EJHaem Haematologic Malignancy ‐ Lymphoid To explore the prognostic values of baseline 2‐deoxy‐2‐[(18)F] fluoro‐D‐glucose (FDG) positron emission tomography/computed tomography (PET/CT) dissemination parameter in angioimmunoblastic T‐cell lymphoma (AITL) and its added values to total metabolic tumour volume (TMTV). Eighty‐one AITL patients with at least two FDG‐avid lesions in baseline PET/CT were retrospectively included. PET parameters including TMTV and the distance between the two lesions that are the furthest apart (Dmax) were obtained. Univariate Cox analysis showed that both Dmax and TMTV were risk factors for progression‐free survival (PFS) and overall survival (OS). Multivariate Cox analysis models of different combinations showed that high Dmax (> 65.7 cm) could independently predict both PFS and OS, while high TMTV (>456.6 cm(3)) was only significant for OS. A concise PET model based on TMTV and Dmax can effectively risk‐stratify patients. PFS and OS rates were significantly lower in patients with high Dmax and high TMTV than in patients with low Dmax and low TMTV (3‐year PFS rate: 15.0% vs. 48.7%, p = 0.001; 3‐year OS rate: 27.6% vs. 79.0%, p < 0.001). Dmax can directly reflect the disease dissemination characteristic and has a significant prognostic value for FDG‐avid AITL patients. It has the potential to be introduced into new risk stratification models for tailored treatment. John Wiley and Sons Inc. 2022-11-29 /pmc/articles/PMC9928789/ /pubmed/36819177 http://dx.doi.org/10.1002/jha2.610 Text en © 2022 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Haematologic Malignancy ‐ Lymphoid
Gong, Huanyu
Tang, Bo
Li, Tiannv
Li, Jianyong
Tang, Lijun
Ding, Chongyang
The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma
title The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma
title_full The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma
title_fullStr The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma
title_full_unstemmed The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma
title_short The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma
title_sort added prognostic values of baseline pet dissemination parameter in patients with angioimmunoblastic t‐cell lymphoma
topic Haematologic Malignancy ‐ Lymphoid
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928789/
https://www.ncbi.nlm.nih.gov/pubmed/36819177
http://dx.doi.org/10.1002/jha2.610
work_keys_str_mv AT gonghuanyu theaddedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma
AT tangbo theaddedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma
AT litiannv theaddedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma
AT lijianyong theaddedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma
AT tanglijun theaddedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma
AT dingchongyang theaddedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma
AT gonghuanyu addedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma
AT tangbo addedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma
AT litiannv addedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma
AT lijianyong addedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma
AT tanglijun addedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma
AT dingchongyang addedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma